1996
DOI: 10.1159/000159185
|View full text |Cite
|
Sign up to set email alerts
|

Impairment of Acetylcholine Relaxations by Malondialdehyde, a Marker of Lipid Peroxidation

Abstract: The effect of malondialdehyde (MDA), a lipid peroxidation marker, on the relaxations evoked by acetylcholine (ACh) was analyzed in tail arteries of Sprague-Dawley rats, which have MDA plasma levels of 0.43 ± 0.10 µM. MDA (0.5–30 µM) produced an inhibition of ACh relaxations that persisted after repeated washing periods, and was independent of the incubation time. MDA did not modify the vasodilator responses to either exogenous nitric oxide (NO) or sodium nitroprusside, a NO donor. L-Arginine (the NO synthase s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
9
0

Year Published

1998
1998
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 32 publications
0
9
0
Order By: Relevance
“…However, no differences in basal free 3-nitrotyrosine levels were found between non-tolerant SHR and WKY. Nevertheless, a difference in ONOO À release between SHR and WKY cannot be excluded, since the protein-bound 3-nitrotyrosine concentration was not assessed in the present study and an increase in protein-bound 3-nitrotyrosine in aortas from aortic banding-induced hypertensive rats was recently demonstrated [34]. Neither treatment with NAC nor melatonin changed the free 3-nitrotyrosine level in nontolerant rats of both strains, but they prevented the rise of free 3-nitrotyrosine in coronary ef¯uent of tolerant SHR.…”
Section: Discussionmentioning
confidence: 84%
“…However, no differences in basal free 3-nitrotyrosine levels were found between non-tolerant SHR and WKY. Nevertheless, a difference in ONOO À release between SHR and WKY cannot be excluded, since the protein-bound 3-nitrotyrosine concentration was not assessed in the present study and an increase in protein-bound 3-nitrotyrosine in aortas from aortic banding-induced hypertensive rats was recently demonstrated [34]. Neither treatment with NAC nor melatonin changed the free 3-nitrotyrosine level in nontolerant rats of both strains, but they prevented the rise of free 3-nitrotyrosine in coronary ef¯uent of tolerant SHR.…”
Section: Discussionmentioning
confidence: 84%
“…It has been demonstrated that MDA inhibits the endothelium-dependent vasorelaxation to acetylcholine in the tail artery of normal rats [32]. Additionally, NO also plays a major key role in the development of hyperdynamic circulation and portal hypertension in cirrhosis [18].…”
Section: Discussionmentioning
confidence: 99%
“…Recently, we demonstrated, for the first time, that MDA produces a reduction of endothelium‐dependent relaxations to ACh in the tail artery from adult SD rats (6 months) (Rodríguez‐Martínez et al , 1996). In the present study, we have assessed the effect of age on the vascular actions of MDA, associated with age‐related changes in the blood prooxidant‐antioxidant state of the animals.…”
Section: Discussionmentioning
confidence: 96%